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Abstract
Introduction and hypothesis Stress urinary incontinence
(SUI) is the most common form of incontinence impacting
on quality of life (QOL) and is associated with high financial,
social, and emotional costs. The purpose of this study was to
provide an update existing Dutch evidence-based clinical
practice guidelines (CPGs) for physiotherapy management
of patients with stress urinary incontinence (SUI) in order to
support physiotherapists in decision making and improving
efficacy and uniformity of care.
Materials and methods A computerized literature search of
relevant databases was performed to search for information
regarding etiology, prognosis, and physiotherapy assessment
and management in patients with SUI. Where no evidence
was available, recommendations were based on consensus.
Clinical application of CPGs and feasibility were reviewed.
The diagnostic process consists of systematic history taking
and physical examination supported by reliable and valid
assessment tools to determine physiological potential for re-
covery. Therapy is related to different problem categories. SUI
treatment is generally based on pelvic floor muscle exercises
combined with patient education and counseling. An impor-
tant strategy is to reduce prevalent SUI by reducing influenc-
ing risk factors.
Results Scientific evidence supporting assessment and man-
agement of SUI is strong.
Conclusions The CPGs reflect the current state of knowledge
of effective and tailor-made intervention in SUI patients.
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Abbreviations
BMI Body mass index
CPGs Clinical practice guidelines
COPD Chronic obstructive pulmonary disease
EBRO Evidence- Based Richtkijn (Guideline)
Ontwikkeling (Development)
GPE Global Perceived Effect scale (measurement
instrument)
ICF International Classification of Functioning,
Disability and Health
PFM Pelvic floor muscles
PFMT Pelvic floor muscles training
PRAFAB Protection, Amount, Frequency, Adjustment
Body Image (measurement instrument)
PSC Patient-Specific Complaints (measurement
instrument)
SUI Stress urinary incontinence
UI Urinary incontinence
VC Vaginal cones
Introduction
Stress urinary incontinence (SUI) is the most common form of
urinary incontinence (UI) [1, 2]. It often severely impacts on
quality of life (QOL) [3] and is associated with high financial,
social, and emotional costs [4, 5]. This article is based on an
updated, state-of-the-art, evidence-based physical therapy
guideline [6] and gives extra attention to the following
topics: definition of SUI, the biopsychosocial model,
SUI etiology, and prognostic factors that may predict phys-
iotherapy success. Definitions are according to the
International Continence Society (ICS) and the International
Urogynecological Association (IUGA) [7]. The guidelines
involve diagnosis and treatment of adult patients with
(predominant) SUI.
The biopsychosocial model assumes that SUI involves a
decrease in resilience of the pelvic floor that may lead to
impairments in physical and mental functioning, restrictions
in activities, and in participation [8]. This model addresses the
consequences of SUI, taking into account prognostic factors
that may influence recovery and emphasizing the role of
physical, psychological, and social factors in the development
and/or persistence of SUI.
The total urethral closing mechanism consists of two
combined mechanisms ensuring urinary continence, i.e.,
an intrinsic urinary sphincteric closure mechanism and
an extrinsic urethral- and vaginal-wall support mecha-
nism [9]. The former depends on three different layers
in the wall of the urethra—the tunica mucosa, the
spongiosa, and the muscularis—whereas the latter de-
pends on the supportive function of the pelvic floor.
The major components of this supportive structure are
the vaginal wall, the endopelvic fascia, the arcus
tendineus fasciae pelvis, and the levator ani muscles
[9]. SUI can develop if there is dysfunction in one or
both of these mechanisms [10]. Etiological factors of
SUI are as follows:
1. Intrinsic (urethral) closure mechanism
& Atrophy of the tunica mucosa and the tunica
spongiosa (estrogen deficiency, e.g., postmenopausal)
& Dysfunctional tunica muscularis (e.g., due to surgical
interventions such as transurethral prostate resection
or radical prostatectomy or trauma)
2. Extrinsic support mechanism
& Weak pelvic floor muscles and ligaments
& Pregnancy
& Vaginal delivery
& Instrumental delivery (vacuum or forceps)
& Episiotomy
& Maternal age at first delivery ≤30 years
& Parity, increasing after three or more deliveries
& Being overweight [25≤body mass index (BMI)<30]
& Consuming carbonated drinks
& Age
Prognosis for recovery in SUI depends on the nature of the
underlying disorder and/or disease process. Prognostic factors
for reduced chance of spontaneous recovery and recovery
after physiotherapy were identified through prospective co-
hort studies.
1. Reduced chance of recovery
& Increasing severity of the SUI
& Previous conservative treatment for SUI with an un-
favorable outcome
& SUI during pregnancy and during the first 3 months
after delivery
& Number of pregnancies
& Prolonged second stage of labor
& Severe prolapse [Pelvic Organ Prolapse Quantification
system (POP-Q) stage 3 or 4]
& Being overweight
& Presence of other diseases or disorders, such as chronic
obstructive pulmonary disease (COPD) and cardiovas-
cular diseases
& Psychological strain
& Patient-perceived low physical condition
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2. Increased chance of recovery
& Higher educational level
& Higher level of motivation for and adherence to a
pelvic floor training program
Literature search
For the period 1998 to September 2012, the following data-
bases were searched: PubMed, MEDLINE, Embase,
CINAHL, PEDro, and the Cochrane Database, for publica-
tions on SUI nature, severity, physiotherapeutic diagnostic
procedures, and preventive and therapeutic interventions.
Additional tracking of further relevant publications was
performed. Methodological quality of individual studies was
graded following the criteria for Evidence-Based Guideline
Development (EBRO) criteria [11] in order to formulate rec-
ommendations for the guideline and assess the quality of the
other aspects—in addition to scientific evidence—that are
important for formulating recommendations, such as achiev-
ing general consensus, efficiency (costs), resource availability,
required therapist expertise and training, organizational as-
pects, and efforts to harmonize the guidelines with other
monodisciplinary or multidisciplinary guidelines. The meth-
odology used to formulate its recommendations is presented
in Table 1.
Establishment of consensus
If no scientific research was available to guide clinical reason-
ing, recommendations were made based on established con-
sensus. Clinical experts in the development team had to make
their clinical reasoning explicit, explain their clinical exper-
tise, and explain which concepts and ideas were used in their
clinical reasoning. Recommendations were subsequently
based on consensus that was established after discussion
within the development team of the concepts used.
Biological/physiological plausibility was a guiding principle.
A summary of the recommendations is presented at the end of
the article.
Diagnostic process
The diagnostic process is based on systematic reviews [12]
and other relevant Dutch guidelines [13]. During this process,
which is used to formulate a specific treatment plan, the nature
of the underlying disorder and SUI severity (assessed on the
basis of the ICF [8]) are examined in the context of whether
the underlying disorders and/or any identified unfavorable
prognostic factors are modifiable by physiotherapy. Goal-
oriented and systematic history taking involved medical, para-
medical, communicative, and attitudinal aspects. Type of in-
continence, estimation of volume of urine loss, impact, and
identification of any underlying disorder and factors
Table 1 Levels of evidence: classification of methodological quality of individual studies
Intervention Diagnostic accuracy of study Harm/side-effects, etiology, prognosisa
A1: Systematic review of at least two
independent A2-level studies
A2: Randomized, double-blind,
comparative clinical trial of good
quality and sufficient sample size
Study compared with a reference test
(gold standard) with predefined cutoff
values and independent assessment of
outcomes of the test and the gold standard,
based on a sufficiently large sample of
consecutive patients, all of whom have
undergone the index and reference tests
Prospective cohort study with sufficient sample
size and follow-up, effectively controlled for
confounding and with effective measures to
prevent selective follow-up
B: Comparative study not meeting
all criteria mentioned under A2
Study compared with a reference test, not
meeting all criteria mentioned under A2
Prospective cohort study not meeting all criteria
mentioned under A2, or retrospective cohort study
C: Noncomparative study
D: Expert opinion
Level of conclusions.
Conclusion based on: Recommendations based on conclusion level:
1. Study at A1 level or at least two
independent A2-level studies
It has been demonstrated that…
2. One study at A2 level or at least
two independent B-level studies
It is plausible that…
3: One B- or C-level study There are indications that…
4. Expert opinion In the opinion of the guideline development team,…
a This classification is only relevant for situations in which controlled trials are impossible due to ethical or other considerations. If controlled trials are an
option, the classification for interventions is to be used
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contributing to incontinence (e.g., use of medication and
alcohol, abnormal fluid intake, limitations, and comorbidity)
are assessed. UI description in relation to precipitating factors,
social impact, effect on hygiene and QOL, measures taken to
control UI, and the patient’s illness beliefs are assessed [12]. In
addition, particularly in primary care, the Incontinence
Questionnaire (3IQ) test is useful for assessment of type of
UI [14]. The severity of the patient’s health problem is
assessed by using the ICF, determining frequency and UI
volume, use of absorptive products, and impact of UI on
everyday life, including work, sports, housekeeping activities,
family life, social life, and sexuality. Illness beliefs can have a
favorable or adverse effect on the prognosis in terms of
recovery and should be identified because beliefs may partly
determine the type of intervention that can be used and can
affect expectations of both the patient and the physiotherapist
[15]. Physical examination includes inspection at rest and
during movement, vaginal and/or rectal palpation, and func-
tional examination, assessing:
& Level of voluntary and involuntary control of the pelvic
floor, coordination of the pelvic floor muscles (PFM), and
synergistic activity
& Quantification and symmetry of (in)voluntary PFM con-
traction and relaxation
& Other PFM functions, such as endurance, fatigue
& Whether and to what extent other aspects of the musculo-
skeletal system, such as respiration, lower back, pelvis,
and hip, are hampering PFM function
& Any local and other (i.e., general) unfavorable prognostic
factors
Physical examination provides information about whether
an inward movement is visible/palpable on contraction,
whether any cocontraction and relaxation is visible/palpable,
and whether movement of the perineum is visible on coughing
and straining [16]. Vaginal or rectal palpation enables the
therapist to evaluate the correct performance of PFM contrac-
tion and relaxation [16]. The contraction may be categorized
as being absent, weak, normal, or strong. Relaxation can be
rated as absent, partial, or complete [17]. Assessment of PFM
tonicity is hampered by the fact that there are as yet no
generally accepted definitions for the terms normal tonus,
hypertonus, and hypotonus [17]. The ICS Pelvic Floor
Clinical Assessment Group has opted for a summary descrip-
tion as being a condition: PFM could therefore be normal,
overactive, underactive, or nonfunctioning [17]. To evaluate
PFM function, use of the following assessment schedule,
described in the practice guidelines, is recommended:
& Assess whether the patient is able to voluntarily contract
and relax the PFM, and evaluating the performance
& Assess the effectiveness of voluntary contraction and re-
laxation of the PFM
& Assess the effectiveness of involuntary contraction of the
PFM associated with a sudden increase in intra-abdominal
pressure (forceful coughing) and subsequently during
coughing after the patient has been instructed to contract
their pelvic floor first
& Assess the effectiveness of involuntary relaxation of the
PFM during straining
& Observe the voluntary contraction and relaxation of the
PFM in relation to the abdominal muscles
& Establish any differences between the right and left sides
while the patient contracts and relaxes the PFM
& Quantify the strength, endurance, and explosive strength
of the PFM
In healthy individuals, intra-abdominal pressure is auto-
matically regulated by feed-forward control of the transversus
abdominis muscle, with the diaphragm and the PFM [18–20].
A strong relationship is described between lower back pain on
the one hand and incontinence and respiratory dysfunction on
the other as the consequence of a limited ability to sufficiently
integrate trunk muscle function in the regulation of posture
and respiration as well as continence [21]. Good voiding
posture and relaxed pelvic floor and breathing create optimal
conditions for voiding the bladder and intestines [22]. The
therapist should inspect the following (level 3) [21, 23]:
& Patient’s sitting and standing posture (urethral angle,
anorectal angle, abdominal pressure, and toileting
behavior)
& Respiration (breath holding and vocal behavior)
& Movements (mobility and tonicity of the spinal column,
abdominal, and pelvic regions and movement patterns)
& Abdominal, buttock, and leg muscles (patients with fa-
tigued PFM often show increased activity of other
muscles)
Local resilience can be reduced as a result of rupture or
incisional scars by anterior or posterior vaginal wall defects or
by uterine prolapse. Inspection can be used to identify signs of
reduced pelvic floor resilience. The patient’s specific resilience
can be estimated from her general physical condition. Obesity
is an unfavorable prognostic factor for recovery (level 3) [24]
and can be assessed using BMI measurement [24].
Measurement instruments
UI severity and consequences for everyday life, patient’s
adjustment to the problem and significance for the pa-
tient’s sense of self-esteem, and physiotherapeutic effect
changes are measured and evaluated. The Protection,
Amount, Frequency, Adjustment Body Image (PRAFAB)
questionnaire measures UI severity in terms of use of
absorptive products (PRotection), volume (Amount), and
occurrences (Frequency) (leakage severity scale), impact
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in terms of patient adjustment to UI in everyday life
(Adjustment), and consequences for patient’s self-image
(Body image) (perceived impact scale) [25].. It can be
used to record changes in individual health status (level
2) [26]. UI can be quantified by weighing incontinence
pads used after a specified period of time. A 24-h pad test
is a reliable instrument for assessing UI loss (level 2) [12,
27]. The Patient-Specific Complaints (PSC) instrument
enables the patient to indicate the main activities in which
they feel restricted and helps the physiotherapist determine
the patient’s subjective functional status before and after
treatment, making the instrument suitable for (effect) eval-
uation [28]. The Global Perceived Effect (GPE) scale
indicates the patient’s general perception of subjective
health status improvement (level 2) [29, 30]. On a 3-day
micturition diary, UI severity, i.e., number of incontinent
episodes and result of treatment, is assessed (level 1) [31].
The diary can also be used to give specific feedback and
advice to the patient on the timing of eating/drinking,
micturition, and toileting behavior [22, 32].
Analysis of all gathered data involves the explicit decision
as to whether physiotherapy is indicated. For modifiable prog-
nostic factors, explicit physiotherapeutic goals are formulated
[33]. Based on the analysis, a number of problem categories
can be distinguished:
SUI with PFM dysfunction:
& The patient is unable to identify their PFM, has no aware-
ness, cannot manage contraction or relaxation, shows no
effective involuntary contraction of the PFM associated
with increased abdominal pressure
& The patient is unable to identify their PFM, has no aware-
ness, cannot manage contraction or relaxation, shows
some involuntary contraction of the PFM associated with
increased abdominal pressure, but contraction is
ineffective
& The patient is unable to identify their PFM, has no aware-
ness, cannot manage contraction or relaxation, but shows
effective involuntary contraction of the PFM associated
with increased abdominal pressure
& The tone of the PFM is measurably too high, and the
patient is unable to reduce this on demand (with or without
voluntary tightening and with or without effective invol-
untary contraction associated with increased abdominal
pressure)
& The patient is able to tighten and relax the PFM but has no
effective involuntary control over the PFM associated
with increased abdominal pressure
& The patient has both voluntary and involuntary control
over the PFM, but the PFM are too weak
& The functioning of other parts of the musculoskeletal
system, e.g., in relation to respiration, voiding posture,
and toileting behavior, adversely affects PFM function
SUI without PFM dysfunction:
& SUI plus local and/or other (general) unfavorable prog-
nostic factors that may have adverse local or general
effects on recovery and/or adjustment processes, and
which may or may not be modifiable by physical therapy
interventions
Treatment plan
Depending on the modifiability of the SUI condition, objec-
tives of physiotherapy are defined. PFM training (PFMT)
should aim not only to increase the physical condition of the
pelvic floor, but also to maintain it (use it or lose it). This
requires permanent active involvement and changes to the
patient’s lifestyle. Physiotherapy needs to support this behav-
ioral change. In addition, the patient’s general physical condi-
tion must be optimized in order to reduce the influence of
other diseases and/or disorders on the continence mechanism.
First, information and explanation about the nature of the
patient’s problem is given. Patients are more motivated to start
the therapy if they understand normal anatomy and physiolo-
gy, the influence of (mental) stress and relaxation on PFM
functioning, and the causes and development of SUI [34].
This type of patient-specific education must be a standard
treatment plan component.
Therapeutic process
Therapeutic interventions aim to:
1. Provide information and advice. This includes explana-
tion about risk and prognostic factors in general and
specific to the patient, lifestyle advice, and the use of
anatomical diagrams and pelvic models (level 4).
2. Improve general physical condition. UI risk decreases
with increasing level of moderate physical activity [35,
36] (level 3).
3. Improve functional condition of the pelvic floor:
(a) PFM training to enable voluntary contraction and
relaxation, increase strength and endurance, and pro-
mote involuntary contraction to support increase in
intra-abdominal pressure.
The goal of PFM training is to improve the extrinsic
support mechanism to such an extent that the pelvic
floor provides enough support to prevent UI loss asso-
ciatedwith increased intra-abdominal pressure [37, 38].
Supervised and intensive PFMT results in complete
recovery or at least considerable improvement in 60–
70%ofwomenwith SUI (level 1) and to a reduction in
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subjective symptoms (level 1). This improvement can
be objectively confirmed by urodynamic examination
and a pad test (level 1). PFMT also results in objective
improvement of the PFM function (level 1) and in the
patient’s QOL (level 1). There are no adverse or
side effects (level 1). Its success rate can be improved
by checking whether patients carry out PFME cor-
rectly (level 1) [39] and that teaching women with
SUI to contract their PFM just before and during an
increase in intra-abdominal pressure is an effective
treatment method (level 1) [37].
The training program should be designed to be
realistically feasible in order to promote compliance.
It must be possible to integrate the exercises into
everyday activities. PFMTeffect is partly determined
by training frequency and duration of the training
period (level 2) [40, 41]. Daily PFMTwith sufficient
intensity and duration is recommended [39] while
paying attention to the correct performance and –
ultimately—integration into daily life activities of
the exercises (level 4).
Prognostic factors such as patient’s physical fit-
ness, whether overweight, and comorbidities such as
cardiovascular diseases or COPD have an adverse
effect on the development and persistence of SUI,
therefore on the effect of PFMT (level 3) [42], and
should, if modifiable, be incorporated into the inter-
vention strategy.
(b) Biofeedback
Biofeedback uses an external sensor to assess a
bodily process, usually with the intention of altering
the variable being measured [43]. Biofeedback is not
a therapy in itself but can be used combined with
PFMT in SUI treatment to indicate PFM activity at
rest, on contraction, and in relaxation. Furthermore,
it can indicate the strength of individual PFM con-
tractions (electromyogram), strength of the
contracting PFM (pressure measurement) or the
way in which certain muscles contract, and the di-
rection of contraction (ultrasound). The combination
is no more effective than PFMT alone [37, 38, 42,
44, 45]. Both treatment modalities are effective,
whereas biofeedback may have added value in SUI
patients with insufficient awareness and/or control of
the pelvic floor, may speed up initial improve-
ment, and may support motivation to keep exercis-
ing (level 4) [46].
(c) Electrical stimulation
The goal of electrical stimulation in the treatment
of patients with SUI is to make the PFM contract,
with the aim of achieving a training effect to ensure
that the pelvic floor will provide sufficient support to
prevent UI loss during an increase in intra-abdominal
pressure. There is insufficient evidence that electrical
stimulation alone is an effective treatment for pa-
tients with SUI (level 1), and the addition of electri-
cal stimulation to PFMToffers no additional benefits
(level 1) [47, 48].
However, it might be useful to support the initial
steps toward a functional training program by pro-
viding a better awareness of how to (correctly) con-
tract the PFM in patients with insufficient voluntary
control and capacity. This statement needs further
research [38, 47].
(d) Vaginal cones
The goal of using vaginal cones (VC) is to train the
PFM by contracting them to hold a weight inserted
into the vagina. If the patient manages to hold a
particular weight, it is then replaced by a slightly
heavier weight. VC effectiveness compared with no
treatment or combined PFMT and electrical stimula-
tion remains unclear (level 1) [38]. On the other hand,
combining PFMT with VC in accordance with the
general principles of strength training may be effec-
tive (level 3) [45]. However, many women find VC
training difficult and uncomfortable (level 1) [38].
Preventing SUI
Continent primigravidae women should be offered a super-
vised and intensive antepartum strengthening PFMT program
to prevent postpartum UI (level 1) [38, 39].
Evaluation
Because the nature and/or severity of the underlying disorder
at referral is often unclear, there may be impediments to
recovery that cannot be modified by physiotherapy.
Therefore, early evaluation after a pilot treatment of six ses-
sions is recommended. Where there has been no progress on
the PRAFAB and/or GPE, physiotherapy should be
interrupted, referring the patient back for further investigation
and/or treatment, such as surgery. As good physical condition
of the pelvic floor is a favorable prognostic factor for postop-
erative recovery after surgical intervention, physiotherapy can
be regarded as useful.
Interaction between physiotherapists
and other health-care providers
Most patients will see the physiotherapist through referral
by a medical doctor who believes that physiotherapy may
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make an important contribution to reducing the problem.
Communication between doctor and physiotherapist about
etiology and prognostic factors is necessary. Back referral
is necessary if complications arise during the treatment
period or when, despite therapy, incontinence severity
insufficiently decreases. It is possible that surgery may
be an option in such cases. The patient must be referred
back to the referring doctor if treatment goals are not met
but the physiotherapist estimates that the patient has
achieved the maximum possible result. If the patient ap-
proaches the physical therapist directly, special agree-
ments are made. If the diagnosis is unclear, the patient
should be referred to a medical doctor. For patients who
must undergo a prostatectomy, the urologist can ask the
physical therapist to teach the patient specific exercises
preoperatively and provide instructions for postoperative
exercises to implement after catheter removal.
Discussion
These guidelines, based on state-of-the-art evidence, serve to
assist physiotherapists in diagnosing and treating patients with
UI. The main benefits of the CPGs are to improve the quality
of care, provide uniformity in care, and make physiotherapy
more transparent to the referring physician and to patients [48,
49]. Guidelines should be followed, but physiotherapists may
deviate from them if there are good reasons to do so.
Conclusions of systematic reviews form the main basis for
intervention recommendations. Because not all recommended
interventions are evidence based, these guidelines may con-
tain some bias [50]. The use of guidelines requires the phys-
iotherapist to be constantly aware of specific patient charac-
teristics and the applicability of evidence-based recommenda-
tions. This will help physiotherapists in decision making and
in optimising the quality of care.
An important strategy when using these guidelines is to
reduce prevalent SUI by reducing the risk and by
diminishing the influence of prognostic factors. An early
distinction between patients with SUI based on the pres-
ence of prognostic factors would allow early selection of
patients who need additional treatment and would help to
set treatment goals.
Physiotherapists who use these guidelines need to under-
stand the nature of the SUI, the influence of prognostic factors,
the available scientific evidence, and the principles of behav-
ioral therapy. Because education and progressive exercises are
important components of behavioral therapy, physiotherapists
should provide them. By increasing the ability to carry out
activities and demonstrating that physical activity is beneficial
and may relieve symptoms, physiotherapists may contribute
to movement behavior modification and to changes in cogni-
tions about incontinence.
Implementation activities are planned for the future. For
useful implementation, the development of effective strategies
is of the utmost importance.
Conclusion
Clinical practice guidelines presented here for physiotherapeutic
management of SUI patients have been developed and updated
to assist physiotherapists in providing appropriate care. Overall,
evidence was strong, although the guidelines also reflect con-
sensus among experts when evidence was lacking. The guide-
lines reflects the current state of knowledge about effective and
appropriate physiotherapeutic care of patients with SUI. Better
quality research is needed to validate the consensus-based
recommendations.
A summary of recommendations follows:
1. Problem definition
& Identifying etiological factors—the therapist should
systematically identify etiological factors in order to
assess the nature of the dysfunction of the continence
mechanism (level 4)
2. Diagnostic process
& Establishing the type of incontinence—the guideline
development team recommends using the 3IQ test to
establish the type of incontinence (level 1)
& Palpation—the guideline development team recom-
mends the use of the assessment procedure described
in the practice guideline to evaluate PFM function
(level 2)
& Functional examination—the guideline development
team recommends that breathing patterns, postural
control, voiding posture, and toileting behavior be
examined in relation to functioning of PFM (level 3)
& PRAFAB questionnaire—the guideline development
team recommends using the PRAFAB questionnaire
to assess changes in the patient’s health status and the
effect of physical therapy intervention (level 1)
& Quantifying the loss of urine—the guideline develop-
ment team recommends quantifying the loss of urine
using the 24-h pad test in case of uncertainty about the
quantities of urine being lost (level 3)
& Patient-Specific Complaints (PSC)—the guideline
development team recommends using the PSC both
to identify the health problem and to evaluate the
effect of treatment (level 2)
& Global Perceived Effect (GPE)—the guideline devel-
opment team recommends using the GPE to evaluate
the health status improvement perceived by the pa-
tient (level 2)
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& Micturition diary—the guideline development team
recommends having patients keep a micturition diary
in order to identify the severity of the loss of urine and
to evaluate the results of treatment (level 1)
3. Therapeutic process
& Information and advice—the guideline development
team recommends the use of anatomical plates and
pelvic phantoms, as well as other educational mate-
rials such as lifestyle advice (level 4)
& Improving general physical condition—the guideline
development team recommends the inclusion in the
treatment plan of interventions to improve the pa-
tient’s general physical condition (level 4)
& Frequency and performance of PFMT—the guideline
development team recommends treating SUI by
means of daily PFMT with sufficient intensity and
duration while paying attention to the correct perfor-
mance of the exercises and integrating the exercises
into activities of daily life (level 1)
& Selective contraction of PFM—the guideline develop-
ment team recommends combining PFM exercises with
electrostimulation in patients who are unable to volun-
tarily and/or selectively contract their PFM (level 3)
4. Prevention
& PFM training to promote postoperative recovery after
prostatectomy—the guideline development team rec-
ommends preoperative PFM training for men who
have to undergo prostatectomy (level 2)
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